Screener
Vertex Pharmaceuticals VRTX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000875320-26-000173
FAQ
- What is Vertex Pharmaceuticals's free cash flow margin?
- Vertex Pharmaceuticals (VRTX) reported free cash flow margin of 30.4% in Q1 2026.
- How has Vertex Pharmaceuticals's free cash flow margin changed year-over-year?
- Vertex Pharmaceuticals's free cash flow margin increased by 198.0% year-over-year, from -31% to 30.4%.
- What is the long-term trend for Vertex Pharmaceuticals's free cash flow margin?
- Over 4 years (2020 to 2025), Vertex Pharmaceuticals's free cash flow margin has grown at a -13.8% compound annual growth rate (CAGR), from 48.2% to 26.6%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Vertex Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude